# Immunology and Microbiology Devices; Reclassification of Herpes Simplex Virus (Types 1 and/or 2) Serological Assays; Correction
**AGENCY:**
Food and Drug Administration, HHS.
**ACTION:**
Proposed rule; correction.
**SUMMARY:**
The Food and Drug Administration is correcting a proposed rule that appeared in the *Federal Register* of January 9, 2006 (71 FR 1399). That document proposed the reclassification of herpes simplex virus (types 1 and/or 2) serological assays from class III (premarket approval) to class II (special controls). That document inadvertently included a list of references related to a draft guidance that also was announced in the *Federal Register* of January 9, 2006 (71 FR 1432). The draft guidance contains the correct list of references. This document corrects the error.
**FOR FURTHER INFORMATION CONTACT:**
Sally Hojvat, Center for Devices and Radiological Health (HFZ-440), Food and Drug Administration, 2098 Gaither Rd., Rockville, MD 20850, 240-276-0496, ext. 114.
**SUPPLEMENTARY INFORMATION:**
In FR Doc. 06-173, appearing on page 1399, in the *Federal Register* of Monday, January 9, 2006, the following correction is made:
1. On pages 1402-1403, section XII. References is removed.
Dated: March 3, 2006.
Linda S. Kahan,
Deputy Director, Center for Devices and Radiological Health.